Anika Therapeutics (ANIK) Tops Q3 EPS by 35c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $21.79 +1.11%
EPS Growth %: +950.0%
Financial Fact:
Basic weighted average common shares outstanding: 14.63M
Today's EPS Names:
PFBX, GOVB, VABK, More
EPS Growth %: +950.0%
Financial Fact:
Basic weighted average common shares outstanding: 14.63M
Today's EPS Names:
PFBX, GOVB, VABK, More
Join SI Premium – FREE
Anika Therapeutics (NASDAQ: ANIK) reported Q3 EPS of $0.00, $0.35 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $41.5 million versus the consensus estimate of $38.27 million.
For earnings history and earnings-related data on Anika Therapeutics (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SPS Commerce (SPSC) Tops Q3 EPS by 16c; Offers Guidance
- Chain Bridge Bancorp, Inc. (CBNA) Tops Q3 EPS by 166c
- Virginia National Bankshares Corporation. (VABK) Tops Q3 EPS by 120c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
